Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Clinical trial NCT07403825 · RECRUITING

Trial details

NCT number: NCT07403825
Sponsor: Biobizkaia Health Research Institute
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Macular Degeneration, Age Related

Start date: 2026-05-25
Primary completion: 2028-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.